CERSI-AI Events
The Latest Events from Cersi AI
Smarter Regulation for Better Innovation
WHAT WE DO FOR HEALTHCARE
"We work with innovators, regulators, patients and the NHS to optimise the regulation of AI and Digital Healthcare so as to accelerate innovation that will improve people’s lives."
Future Events
“Getting today’s regulatory system ready for tomorrow’s technologies.”
Our People - Back Up
Our People
Smarter Regulation for Better Innovation
OUR LEADERSHIP & DEVELOPMENT TEAM
"CERSI-AI is led by an experienced team representing leaders in regulatory science and innovation in AI and Digital Health from across the UK, working with national partners and an international network of experts."
Meet the Team
We are the UK’s national Centre of Excellence for Regulatory Science and Innovation in AI and Digital Health. We work with innovators, regulators, patients and the NHS to optimise the regulation of AI and Digital Healthcare so as to accelerate innovation that will improve people’s lives.
Professor Alastair Denniston
Professor Alastair Denniston is Professor of Regulatory Science and Innovation at the University of Birmingham and Honorary Consultant Ophthalmologist at University Hospitals Birmingham NHSFT. He is a leader in the field of Artificial Intelligence (AI) and Digital Health Technologies.
Ms Charlotte Radovanovic
Charlotte Radovanovic is the Programme Manager at University Hospitals Birmingham NHS Foundation Trust, leading the operational delivery and strategic coordination of CERSI-AI.
Mr Mark Slater (PhD)
Mark Slater is a dedicated Patient and Public Partner for CERSI-AI, where he brings the public perspective to the forefront of AI research and policy in healthcare.
Professor Peter Bannister
Peter Bannister is Managing Director of Romilly Life Sciences and leads on activities related to CERSI AI’s commercial strategy.
Dr Hugh Harvey
Hugh is an ex-consultant radiologist, academic and entrepreneur, currently managing director at Hardian Health. He has helped bring to market dozens of SaMD including artificial intelligence systems, and is widely published and renowned for his insight into the healthtech landscape.
Mr Haris Shuaib
Haris Shuaib is the Founder and CEO of Newton’s Tree, a pioneering startup focused on AI transformation at scale within health and care. He also directs the Fellowships in Clinical Artificial Intelligence.
Professor Ibrahim Habli
Professor Ibrahim Habli is Professor of Safety-Critical Systems at the University of York, specialising in the design and assurance of software-intensive systems, with a strong focus on AI and autonomy.
Mr Andrew Davies
Andrew Davies is Executive Director of Digital Health at the Association of British HealthTech Industries (ABHI), where he works closely with system partners to ensure the UK fully leverages its unique NHS infrastructure to drive both citizen health and economic value through data-driven healthcare.
Mr Robin Carpenter
Robin Carpenter is Head of AI Governance and Policy at Newton’s Tree and an active contributor to CERSI AI’s strategic work.
Dr Joe Antoun
Joe brings a research-led and regulatory-aware perspective to the CERSI AI programme, contributing to our shared work on streamlining the adoption of safe, effective technologies.
Professor David Lowe
Professor David Lowe is an Emergency Medicine Consultant at NHS Greater Glasgow and Clyde, and a Professor at the University of Glasgow. He leads the Digital Health Validation Lab (dhvl.org) within the Living Lab supporting the creation of evidence from concept to clinic for healthtech with a focus on AI and devices.
Danica Baluyot
Danica is a Project Support Officer at University Hospitals Birmingham NHS Foundation Trust. She provides operational and administrative support across projects and events, helping the team ensure that AI in healthcare is safe, effective, and equitable.
AI & Digital Health
Steering Group, Global Opportunities Group & National Council
Our Steering Group brings together leading experts from all sectors and stakeholder groups from across the UK.
Our Global Opportunities Group is chaired by Laura Adams, Senior Adviser to the National Academy of Medicine, USA, and represents experts from around the world. Our National Council represents the senior leadership of the UK’s Health and Life Sciences Ecosystem, including national regulators, government, industry and the NHS.
Patients and the public will be represented in all three groups.
We are currently in the process of appointing and on-boarding to these groups… so please check back later for more information.
Global Opportunities Group Overview and Purpose:
The CERSI-AI Global Opportunities Group (GOG) is a dedicated forum that focuses on identifying, developing, and strengthening international collaborations and opportunities in regulatory science and innovation for AI and digital health. A worldwide collaborative platform, this group connects global experts, innovators, and regulators to explore emerging opportunities, foster partnerships, and drive progress in AI-driven healthcare innovation on an international scale.
The three major functions of the CERSI-AI GOG are to:
- Advise CERSI-AI (as represented by the Executive Director and the Senior Leadership Team) on all CERSI-AI activities, bringing a global perspective to current projects and future proposals.
- Identify and access opportunities for CERSI-AI in a global context, to contribute to relevant initiatives around the world in the regulation and innovation of AI and digital health.
- Horizon scan, identifying at a global level where advances in regulatory approaches to AI are occurring, and helping CERSI-AI learn from these and supporting CERSI-AI in sharing best practice from around the world, wherever it may be found.
Meet the Global Opportunities Group
Ms Laura Adams
Laura L. Adams is a Senior Advisor at the National Academy of Medicine, where she leads initiatives in digital health and evidence mobilisation.
Dr Bilal Mateen
Bilal Mateen, is the inaugural Chief AI Officer at PATH, where he leads the organisation’s AI strategy and oversees programs developing innovative AI solutions to tackle major healthcare challenges, including strengthening regulatory systems for emerging technologies.
Dr Melissa McCradden
Melissa McCradden is the Artificial Intelligence Director and Deputy Research Director at the Women's and Children's Health Network, and a Fellow at the Australian Institute for Machine Learning.
Mr Marc Lamoureux
Marc Lamoureux is the Head of the Digital Health Division at Health Canada. Since 2011, Marc has worked at Health Canada specializing in the technical assessment of medical software, diagnostic imaging devices, and radiotherapy equipment.
Professor Stephen Gilbert
Stephen Gilbert is a leading expert in medical device regulatory science at the Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden, where he leads interdisciplinary research on regulatory frameworks for digital and AI-enabled medical technologies.
Dr Peiling Yap
Peiling Yap is a pharmacist and infectious-diseases epidemiologist with over 15 years of experience in global and public health.
Adjunct Associate Professor Raymond Chua Swee Boon
Quisque sit amet nunc sit amet enim aliquet rhoncus. Aenean faucibus erat a sapien tincidunt, non faucibus velit interdum. Aenean ultrices maximus metus sit amet consectetur. Nullam sed lobortis nulla.
Mr Ran Milman
Ran Milman is Head of AI Policy at the Israeli Ministry of Health and a key contributor to HealthAI, where he plays a central role in shaping global strategies for responsible AI in healthcare.
Mr Russel Pearson
Russell Pearson is the AI Regulatory Policy and Projects Lead at the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), where he leads national efforts to ensure the safe and effective integration of artificial intelligence in healthcare.
Mr Pat Baird
Pat Baird is the Head of Global Software Standards at Philips, where he leads international efforts to develop regulatory frameworks and standards for software and artificial intelligence in healthcare.
CERSI-AI National Council
The CERSI-AI National Council (NC) is an advisory group that provides strategic direction, fosters national and international collaboration, and drives regulatory innovation to support the safe and effective adoption of AI in healthcare. The Council aims to:
- Provide strategic guidance to help CERSI-AI align to areas of national priority and international opportunity where CERSI-AI may have the greatest positive impact, to support the health and wealth of the UK.
- Provide strategic guidance to help CERSI-AI work effectively with other actors within the wider regulatory and innovation landscape to help optimise the UK’s regulatory ecosystem for the innovation and adoption of AI in healthcare.
- Strengthen national and international collaboration between regulatory agencies, relevant arms length bodies, industry leaders, and research institutions within the area of AI health technologies.
- Advocate for evidence-based policy and regulatory development to enable AI innovation while ensuring patient safety.
- To receive advance intelligence from CERSI-AI regarding new discoveries, challenges and opportunities in relation to AI health technologies, that may be relevant to Council Members and their institutions.
AI & Digital Health
Community of Practice
If you are interested in the regulation and safe implementation of AI and advanced digital technologies into healthcare, then this is the community for you. If you are already working in this field – whether researcher, innovator, health professional, regulator or through lived experience – we would like to hear about your work, connect you to others in the community, and explore ways we can work together. If you just want to find out more, then you’re welcome! We will be hosting a wide range of community events from educational seminars, to research updates, and online resources.
We are currently in the process of appointing and on-boarding to these groups… so please check back later for more information.
“Creating the regulatory system of the future for AI and digital health technologies.”
CERSI-AI News
The Latest News from the CERSI-AI Network
Smarter Regulation for Better Innovation
WHAT WE DO FOR HEALTHCARE
"We work with innovators, regulators, patients and the NHS to optimise the regulation of AI and Digital Healthcare so as to accelerate innovation that will improve people’s lives."
Latest News
“Getting today’s regulatory system ready for tomorrow’s technologies.”
Our People
Our People
Smarter Regulation for Better Innovation
OUR LEADERSHIP & DEVELOPMENT TEAM
"CERSI-AI is led by an experienced team representing leaders in regulatory science and innovation in AI and Digital Health from across the UK, working with national partners and an international network of experts."
Meet the Team
Professor Alastair Denniston
Professor Alastair Denniston is Professor of Regulatory Science and Innovation at the University of Birmingham and Honorary Consultant Ophthalmologist at…
Ms Charlotte Radovanovic
Charlotte Radovanovic is the Programme Manager at University Hospitals Birmingham NHS Foundation Trust, leading the operational delivery and strategic…
Mr Mark Slater (PhD)
Mark Slater is a dedicated Patient and Public Partner for CERSI-AI, where he brings the public perspective to the forefront of AI research and policy in…
Professor Peter Bannister
Peter Bannister is Managing Director of Romilly Life Sciences and leads on activities related to CERSI AI’s commercial strategy.
Dr Hugh Harvey
Hugh is an ex-consultant radiologist, academic and entrepreneur, currently managing director at Hardian Health. He has helped bring to market dozens of SaMD…
Mr Haris Shuaib
Haris Shuaib is the Founder and CEO of Newton’s Tree, a pioneering startup focused on AI transformation at scale within health and care. He also directs the…
Professor Ibrahim Habli
Professor Ibrahim Habli is Professor of Safety-Critical Systems at the University of York, specialising in the design and assurance of software-intensive…
Mr Andrew Davies
Andrew Davies is Executive Director of Digital Health at the Association of British HealthTech Industries (ABHI), where he works closely with system partners…
Mr Robin Carpenter
Robin Carpenter is Head of AI Governance and Policy at Newton’s Tree and an active contributor to CERSI AI’s strategic work.
Dr Joe Antoun
Joe brings a research-led and regulatory-aware perspective to the CERSI AI programme, contributing to our shared work on streamlining the adoption of safe,…
Professor David Lowe
Professor David Lowe is an Emergency Medicine Consultant at NHS Greater Glasgow and Clyde, and a Professor at the University of Glasgow. He leads the Digital…
Danica Baluyot
Danica is a Project Support Officer at University Hospitals Birmingham NHS Foundation Trust. She provides operational and administrative support across…
AI & Digital Health
Steering Group, Global Opportunities Group & National Council
Our Steering Group brings together leading experts from all sectors and stakeholder groups from across the UK.
Our Global Opportunities Group is chaired by Laura Adams, Senior Adviser to the National Academy of Medicine, USA, and represents experts from around the world. Our National Council represents the senior leadership of the UK’s Health and Life Sciences Ecosystem, including national regulators, government, industry and the NHS.
Patients and the public will be represented in all three groups.
We are currently in the process of appointing and on-boarding to these groups… so please check back later for more information.
Global Opportunities Group Overview and Purpose:
The CERSI-AI Global Opportunities Group (GOG) is a dedicated forum that focuses on identifying, developing, and strengthening international collaborations and opportunities in regulatory science and innovation for AI and digital health. A worldwide collaborative platform, this group connects global experts, innovators, and regulators to explore emerging opportunities, foster partnerships, and drive progress in AI-driven healthcare innovation on an international scale.
The three major functions of the CERSI-AI GOG are to:
- Advise CERSI-AI (as represented by the Executive Director and the Senior Leadership Team) on all CERSI-AI activities, bringing a global perspective to current projects and future proposals.
- Identify and access opportunities for CERSI-AI in a global context, to contribute to relevant initiatives around the world in the regulation and innovation of AI and digital health.
- Horizon scan, identifying at a global level where advances in regulatory approaches to AI are occurring, and helping CERSI-AI learn from these and supporting CERSI-AI in sharing best practice from around the world, wherever it may be found.
Meet the Global Opportunities Group
Ms Laura Adams
Laura L. Adams is a Senior Advisor at the National Academy of Medicine, where she leads initiatives in digital health and evidence mobilisation.
Dr Bilal Mateen
Bilal Mateen, is the inaugural Chief AI Officer at PATH, where he leads the organisation’s AI strategy and oversees programs developing innovative AI solutions to tackle major healthcare challenges, including strengthening regulatory systems for emerging technologies.
Dr Melissa McCradden
Melissa McCradden is the Artificial Intelligence Director and Deputy Research Director at the Women's and Children's Health Network, and a Fellow at the Australian Institute for Machine Learning.
Mr Marc Lamoureux
Marc Lamoureux is the Head of the Digital Health Division at Health Canada. Since 2011, Marc has worked at Health Canada specializing in the technical assessment of medical software, diagnostic imaging devices, and radiotherapy equipment.
Professor Stephen Gilbert
Stephen Gilbert is a leading expert in medical device regulatory science at the Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden, where he leads interdisciplinary research on regulatory frameworks for digital and AI-enabled medical technologies.
Dr Peiling Yap
Peiling Yap is a pharmacist and infectious-diseases epidemiologist with over 15 years of experience in global and public health.
Adjunct Associate Professor Raymond Chua Swee Boon
Quisque sit amet nunc sit amet enim aliquet rhoncus. Aenean faucibus erat a sapien tincidunt, non faucibus velit interdum. Aenean ultrices maximus metus sit amet consectetur. Nullam sed lobortis nulla.
Mr Ran Milman
Ran Milman is Head of AI Policy at the Israeli Ministry of Health and a key contributor to HealthAI, where he plays a central role in shaping global strategies for responsible AI in healthcare.
Mr Russel Pearson
Russell Pearson is the AI Regulatory Policy and Projects Lead at the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), where he leads national efforts to ensure the safe and effective integration of artificial intelligence in healthcare.
Mr Pat Baird
Pat Baird is the Head of Global Software Standards at Philips, where he leads international efforts to develop regulatory frameworks and standards for software and artificial intelligence in healthcare.
CERSI-AI National Council
The CERSI-AI National Council (NC) is an advisory group that provides strategic direction, fosters national and international collaboration, and drives regulatory innovation to support the safe and effective adoption of AI in healthcare. The Council aims to:
- Provide strategic guidance to help CERSI-AI align to areas of national priority and international opportunity where CERSI-AI may have the greatest positive impact, to support the health and wealth of the UK.
- Provide strategic guidance to help CERSI-AI work effectively with other actors within the wider regulatory and innovation landscape to help optimise the UK’s regulatory ecosystem for the innovation and adoption of AI in healthcare.
- Strengthen national and international collaboration between regulatory agencies, relevant arms length bodies, industry leaders, and research institutions within the area of AI health technologies.
- Advocate for evidence-based policy and regulatory development to enable AI innovation while ensuring patient safety.
- To receive advance intelligence from CERSI-AI regarding new discoveries, challenges and opportunities in relation to AI health technologies, that may be relevant to Council Members and their institutions.
AI & Digital Health
Community of Practice
If you are interested in the regulation and safe implementation of AI and advanced digital technologies into healthcare, then this is the community for you. If you are already working in this field – whether researcher, innovator, health professional, regulator or through lived experience – we would like to hear about your work, connect you to others in the community, and explore ways we can work together. If you just want to find out more, then you’re welcome! We will be hosting a wide range of community events from educational seminars, to research updates, and online resources.
We are currently in the process of appointing and on-boarding to these groups… so please check back later for more information.
“Creating the regulatory system of the future for AI and digital health technologies.”
Contact Cersi-AI
Contact Us
Smarter Regulation for Better Innovation
Contact us for support, media, or general enquiries.
Our team are waiting to hear from you
We'd like to hear from you ...
“Creating the regulatory system of the future for AI and digital health technologies.”
Cersi-AI Research Projects
Research Projects
Smarter Regulation for Better Innovation
WHAT WE FOCUS ON IN OUR SPECIALIST RESEARCH
Our research spans today’s most pressing challenges and tomorrow’s emerging opportunities in AI and digital health. Some of these technologies are already transforming care, while others are still being developed. Across all our work, we aim to ensure that AI is safe, effective, equitable and inclusive, sustainable, technically robust, and affordable for health systems.
Research Projects
Recent projects have explored how to safely implement AI for diabetic eye screening, when large language models become medical devices, what it takes for NHS organisations to be AI ready, and how regulation can remain both protective and enabling. Together, these initiatives reflect our mission to bring innovators, regulators, clinicians, and patients together to shape smarter, more adaptive pathways for safe and impactful AI in healthcare.
Hardian Regulatory Intelligence Platform (HaRi)
HaRi, created by Hardian Health, is a platform designed to enhance transparency in medical device regulation by consolidating fragmented global data into a unified, contextualised view. It aggregates device registrations, safety data, NHS procurement information, and peer-reviewed evidence from sources like Public Access Registration Data Base (PARD), UK, Food and Drug Administration (FDA), USA, The European Database on Medical Devices (EUDAMED), and PubMed, enabling searches across the UK, Europe, USA, Canada, and Australia.
Borderline Manual for Software as a Medical Device (SaMD)/ AI as a Medical Device (AIaMD)
Developing a manual to support innovators in knowing when an AI health technology falls under medical device regulation (in partnership with the MHRA). This project will help improve clarity, compliance and efficiency, accelerating innovation timelines and patient safety. Stay tuned for more updates as this work progresses.
AI Readiness Checklist
This project is developing a comprehensive tool to support NHS health providers in assessing and enhancing their readiness to deploy AI health technologies. The tool includes four key functions:
- Gating – Enables providers to self-assess their AI readiness before procurement and implementation.
- Growing – Identifies gaps in technical maturity and guides digital preparedness improvements.
- Governance – Offers internal and external assurance that AI is deployed safely and responsibly, aligning with regulatory expectations.
- Generalisability – Promotes consistent standards across NHS sites to support scalable, safe, and peer-supported AI adoption.
.
Qualification and classification of Large Language Models
This project explores how large language models (LLMs) used in healthcare can be assessed under existing medical device regulations. By mapping common health-related LLM use cases from published literature, the team will collaborate with regulatory experts to craft Intended Use Statements and apply current regulatory frameworks to determine risk classifications. The goal is to identify whether LLMs can be regulated under existing rules, understand what factors influence their risk level, and provide policy recommendations to key regulatory bodies including MHRA, Care Quality Commission, National Institute for Health Care Excellence, and National Health Service, England.
Optimising SDEs for AI Health Technologies
This project aims to develop and share best practices for the provision of Secure Data Environments (SDEs) to support the development and testing of AI diagnostics within the NHS and beyond. It focuses on defining requirements across key areas including innovation, regulatory compliance, patient safety, equity, cybersecurity, and data privacy. The goal is to ensure that SDEs are optimally designed to enable safe, effective, and equitable AI innovation in healthcare.
Collaborate with us …
If you have a project where you would like CERSI-AI endorsement or support
Primary Research Objectives
Identification of Need
We help Innovators know what to build, by helping the NHS ‘demand signal’, saying what patients and the NHS needs and are willing to pay for.
Project Design
We help Innovators know how to design their products to meet the needs of patients, health professionals and the wider NHS.
Technical Development
We help regulators address technical aspects of AI development, and help them ensure their processes balance the unique opportunities and risks.
Pre-market Evaluation
We work with innovators and regulators to design efficient but robust systems of evaluation to check the product is ready for routine use.
Post-market Surveillance
We design ways to assess that a product is continuing to work safely.
Updates & Withdrawals
We help innovators and the NHS decide when to replace a product, and how to do so safely.
“Ensuring today’s patients can benefit from tomorrow’s technologies.”
About Cersi-AI
About Us
Smarter Regulation for Better Innovation
WHAT WE DO FOR HEALTHCARE
"We work with innovators, regulators, patients and the NHS to optimise the regulation of AI and Digital Healthcare so as to accelerate innovation that will improve people’s lives."
About Us
At CERSI-AI, we work across the health and tech ecosystem to identify and address current and future needs and opportunities in the regulation of AI & Digital Healthcare products and services, using scientific methodology, community engagement and whole system impact. Our vision is to make the UK a global leader in the regulation of AI and digital healthcare, being recognised as the best place for innovators to develop, evaluate and market new products and services, and the best place for patients and health staff to benefit from AI and digitally-enabled healthcare.
Our role and funding
We were established through funding from the UK Government, provided by the UK Research and Innovation (UKRI) funding agency, with the Office of Life Sciences and the Medicines and Health products Regulatory Agency (the MHRA). This funding forms part of the UK Government’s agenda to support innovation across a range of technologies, with AI and Digital Healthcare being one of their priority areas. We work closely with the MHRA, but we also work with all the UK health regulators (such as NICE, CQC and the HRA), and indeed many international regulators such as the FDA (USA), TGA (Australia) and the FSA (Singapore).
It’s not just about ‘what’ we do, it is also about ‘how’ we do it.
Partners
The founding partners and wider community of CERSI-AI bring together the knowledge and skills of the UK’s Universities, the NHS, regulators and industry.
People
Our leadership and wider community represent the UK’s exceptional expertise in regulatory science and the policy and practice of regulation and innovation.
Collaborate
It’s not just about ‘what’ we do, it is also about ‘how’ we do it. We are clear about our destination and how we want to get there. And we’d love you to get involved…
It’s about scientific approaches to optimise the regulatory process, creating the knowledge, tools and standards to ensure that innovation has achieved appropriate safety, quality and performance standards.
Whether you’re a regulatory professional, patient, health professional, or technology creator, your insights and expertise can help shape the future of regulation of AI in healthcare.
Work with us to ensure that patients can trust the technologies that are used in their healthcare to be safe, effective and equitable.
“Ensuring today’s patients can benefit from tomorrow’s technologies.”
CERSI-AI HOMEPAGE
The Centre of Excellence for Regulatory Science & Innovation in AI & Digital Health
Smarter Regulation for Better Innovation
The Centre of Excellence for Regulatory Science & Innovation in AI & Digital Health
Smarter Regulation for Better Innovation
WHAT WE DO FOR HEALTHCARE
"We work with innovators, regulators, patients and the NHS to optimise the regulation of AI and Digital Healthcare so as to accelerate innovation that will improve people’s lives."
Support & Funding
We are the UK’s national Centre of Excellence for Regulatory Science and Innovation in AI and Digital Health. We work with innovators, regulators, patients and the NHS to optimise the regulation of AI and Digital Healthcare, to accelerate innovation that will improve people’s lives.
RESEARCH
Working across the health and tech ecosystem, we use scientific methodology to address today’s needs and unlock tomorrow’s opportunities.
EDUCATION
In partnership with the NIHR-supported Incubator for AI & Digital Healthcare, we will be providing knowledge transfer seminars, workshops, and a wide-range of on-line resources..
POLICY
Working with the multi-regulator AI & Digital Regulations Service and other UK and international policy bodies, we are a source of trusted information for innovators and adopters.
RESEARCH
Working across the health and tech ecosystem, we use scientific methodology to address today’s needs and unlock tomorrow’s opportunities.
EDUCATION
In partnership with the NIHR-Funded Incubator for AI & Digital Healthcare, we will be providing seminars, workshops, and a wide-range of on-line resources.
POLICY
Working with the multi-regulator AI & Digital Regulations Service and other UK and international policy bodies, we are a source of trusted information for innovators and adopters.
Latest News
Research Projects
Our research spans today’s most pressing challenges and tomorrow’s emerging opportunities in AI and digital health. Some of these technologies are already transforming care, while others are still being developed. Across all our work, we aim to ensure that AI is safe, effective, equitable and inclusive, sustainable, technically robust, and affordable for health systems.
“Creating the regulatory system of the future for AI and digital health technologies.”
Creative Digital Agency
Serious creative agency with striking ideas
We’re a creative agency that uses design and code to solve problems.
Acting at the sweet spot between beauty and programing to craft experiences that go beyond. German-winning designer raised in Austria & currently living in New York City.
— Marc Scott, Executive Officer
Interview with Alicja Rudnicka on Automated Retinal image Analysis Systems
Researchers awarded £1M to help the UK unlock the opportunity of AI and digital healthcare whilst ensuring…
